Use of cathepsin h
AssigneeSanofi
InventorsMathias Gebauer, Martin Michaelis, Danping Ding-Pfennigdorff, Anke M. Schulte, Christiane Metz-Weidmann
Life of this patent
Estimating the term…
Abstract
Present invention concerns the use of Cathepsin H. Other aspects of the invention concern methods for screening pharmaceuticals, for diagnosing pain susceptibility and for the treatment of pain.
Claims28
1-17. (canceled)
A method for identifying or analyzing a compound that modulates neuropathic pain comprising administering a test compound to a Cathepsin H model system, and determining whether the test compound modulates the amount or activity of Cathepsin H or a functional fragment or derivative thereof in the system.
A method for identifying or analyzing a compound that modulates neuropathic pain comprising administering a test compound to a Cathepsin H model system, and determining whether the test compound modulates the amount or activity of a reporter in the system.
A method for identifying or analyzing a compound that modulates neuropathic pain comprising:
- a) selecting a compound that modulates the amount or activity of Cathepsin H or a functional fragment or derivative thereof, and
- b) administering the compound to a subject experiencing pain in order to determine whether the pain is modulated.
A method for identifying or analyzing a compound that modulates neuropathic pain in a subject comprising:
- a) assaying a biological activity of Cathepsin H or a functional fragment or derivative thereof in the presence of one or more test compounds in order to identify one or more modulating compounds that modulate the biological activity of Cathepsin H or functional fragment or derivative thereof, and
- b) testing the one or more modulating compounds for their ability to reduce pain, pain sensation, or pain sensitivity in a subject.
A model system of neuropathic pain sensitivity that is based upon Cathepsin H expression.
Dependencies are inferred from the claim text.